Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 11.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2005 to 2009

Recipients with Heart Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 1,002 100.0% 9,077 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 81 8.1% 485 5.3%
OKT3 6 0.6% 187 2.1%
Thymoglobulin 245 24.5% 1,510 16.6%
Zenapax 49 4.9% 1,285 14.2%
Simulect 51 5.1% 1,412 15.6%
Campath 213 21.3% 24 0.3%
Rituximab 3 0.3% 50 0.6%
No Induction Drug Reported 368 36.7% 4,347 47.9%


Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.